Day One Biopharmaceuticals, Inc. Financial Ratios
DAWN / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
DuPont ROE Decomposition (FY2025)
Return on Equity
-24.3%
Profit Margin
-67.8%
Net Income / Revenue
Asset Turnover
0.31
Revenue / Total Assets
Equity Multiplier
1.15
Total Assets / Equity
Composite: -24.3% (reported: -24.3%)
Profitability
Liquidity
Current Ratio
8.02
Quick Ratio
7.91
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.31
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-0.7%
+2.3pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.